Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: A population-based cohort study

QJM: An International Journal of Medicine

Volumn 107, Issue 7, 2014, Pages 537-543

  Shen, T C ^a,b   Lin, C L ^a,c   Chen, C H ^a   Tu, C Y ^a   Hsia, T C ^a   Shih, C M ^a   Hsu, W H ^a   Sung, F C ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Chu Shang Show Chwan Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; TAIWAN; AGE DISTRIBUTION; AGED; ARTHRITIS, RHEUMATOID; COMPLICATION; INCIDENCE; MIDDLE AGED; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SEX RATIO; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84901291261     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu027     Document Type: Article

References (30)

1. Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A. Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 2004; 33:221-7.
2. Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997; 156:528-35.
3. Toyoshima H, Kusaba T, Yamaguchi M. Cause of death in autopsied RA patients. Ryumachi 1993; 33:209-14.
4. Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med 2011; 2011:872120.
5. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-65.
6. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765-73.
7. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers:a descriptive study. Am J Respir Crit Care Med 2002; 166:1078-83.
8. Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers-report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 2012; 106:980-8.
9. Packard TA, Li QZ, Cosgrove GP, Bowler RP, Cambier JC. COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype. Immunol Res 2013; 55:48-57.
10. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, Csizmadia E, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:156-63.
11. Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H, Chida K. Antiendothelial cell antibodies in patients with COPD. Chest 2010; 138:1303-8.
12. Kirkham PA, Caramori G, Casolari P, Papi AA, Edwards M, Shamji B, et al. Oxidative stress-induced antibodies to carbonyl- modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184:796-802.
13. Kuo YB, Chang CA,WuYK, Hsieh MJ, Tsai CH, Chen KT, et al. Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD. Immunol Lett 2010; 128:131-6.
14. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, et al. Antielastin autoimmunity in tobacco smokinginduced emphysema. Nat Med 2007; 13:567-9.
15. Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, et al. Novel autoantigens immunogenic in COPD patients. Respir Res 2009; 10:20.
16. Núñez B, Sauleda J, Antó JM, Julià MR, Orozco M, Monsó E, et al. Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:1025-31.
17. Cheng TM. Taiwan's national health insurance system: high value for the dollar. In: Okma KGH, Crivelli L, eds, Six Countries, Six Reform Models: Their Healthcare Reform:Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. Hackensack, NJ:World Scientific, 2009:171-204.
18. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis, doi: 10.1136/annrheumdis-2013-203380 [Epub 13 August 2013].
19. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation and the risk of rheumatoid arthritis in women. Am J Med 2006; 119:503.e1-9.
20. Bieber V, Cohen AD, Freud T, Agmon-Levin N, Gertel S, Amital H. Autoimmune smoke and fire-coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis. Immunol Res 2013; 56:261-6.
21. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34:J258-65.
22. Zifman E, Amital H, Gilburd B, Shoenfeld Y. Antioxidants and smoking in autoimmune disease-opposing sides of the seesaw? Autoimmun Rev 2008; 8:165-9.
23. Carmi G, Amital H. The geoepidemiology of autoimmunity:capsules from the 7th International Congress on Autoimmunity, Ljubljana, Slovenia, May 2010. Isr Med Assoc J 2011; 13:121-7.
24. Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a casecontrol study in southern Sweden. Rheumatology [Oxford] 2002; 41:563-71.
25. Vermeulen A. Environment, human reproduction, menopause, and andropause. Environ Health Perspect 1993; 101(Suppl. 2):91-100.
26. Yang DH, Tu CC, Wang SC, Wei CC, Cheng YW. Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease. Rheumatol Int, doi:10.1007/s00296-013-2926-6 [Epub 24 December 2013].
27. de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, et al. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts. Ann Rheum Dis, doi: 10.1136/annrheumdis-2013-203940. [Epub 3 January 2014].
28. Rajendrasozhan S, Yang SR, Edirisinghe I, Yao H, Adenuga D, Rahman I. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation:epigenetics in pathogenesis of COPD. Antioxid Redox Signal 2008; 10:799-811.
29. Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K, et al. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol 2008; 20:349-59.
30. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007; 8:84.